Dr. Proleta Datta, MD, PhD

Dr. Datta practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Datta's NPI, 1326393695, was assigned on July 23, 2012. Dr. Datta holds Nebraska license 30734.

Dr. Datta's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Datta's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Datta is also affiliated with Hillsboro Medical Center. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Datta to 1 more hospital, 4 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Datta practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Datta's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Datta's licenses on file in 4 states: Nebraska, California, Oregon and Texas.

CMS data shows 207 Medicare services from Dr. Datta across 7 procedure codes in 2024, for 140 Medicare patients. Medicare paid $17,007 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 140 Medicare patients who saw Dr. Datta in 2024. The largest group is under 65, with 53 patients. 62% of them have high blood pressure, and 54% have high cholesterol. 43% are also on Medicaid. Their average risk score is 1.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Datta's median patient age at 47, with 55% women.

In 2024, Dr. Datta wrote 1,423 Medicare Part D claims for 123 patients. 79% of them were for generic drugs. CMS names the drug for 1,348 of them, across 37 drugs with 11 or more claims each, at $487,439 in total drug cost. In 2023, CMS named 1,099 claims across 35 drugs.

Dr. Datta accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Datta as offering telehealth.

Dmand AI links 14 papers to Dr. Datta, published from 2011 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Drug Resistant Epilepsy, COVID-19 and Pandemics. Dr. Datta has published most often in Epilepsy Behav. Dr. Datta's most frequent co-authors are Lia Deleon Ernst, MD, Danielle Alyse Becker, MD and David C. Spencer, MD.

CMS Open Payments shows 44 general payments to Dr. Datta from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Neurelis, Inc. paid the most, $15,923.